Sagimet Biosciences Statistics

Total Valuation

SGMT has a market cap or net worth of $186.06 million. The enterprise value is -$2.28 million.

Market Cap	186.06M
Enterprise Value	-2.28M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, before market open.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

SGMT has 31.91 million shares outstanding. The number of shares has increased by 13,667.47% in one year.

Shares Outstanding	31.91M
Shares Change (YoY)	+13,667.47%
Shares Change (QoQ)	+9.90%
Owned by Insiders (%)	10.09%
Owned by Institutions (%)	42.51%
Float	16.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	74.64
Forward PS	n/a
PB Ratio	1.02
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 29.11, with a Debt / Equity ratio of 0.00.

Current Ratio	29.11
Quick Ratio	29.05
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.32% and return on invested capital (ROIC) is -22.70%.

Return on Equity (ROE)	-29.32%
Return on Assets (ROA)	-21.54%
Return on Capital (ROIC)	-22.70%
Revenue Per Employee	$200,000
Profits Per Employee	-$2.93M
Employee Count	10
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+57.14%
50-Day Moving Average	3.83
200-Day Moving Average	4.88
Relative Strength Index (RSI)	70.31
Average Volume (20 Days)	1,371,943

Short Selling Information

The latest short interest is 3.98 million, so 12.48% of the outstanding shares have been sold short.

Short Interest	3.98M
Short Previous Month	1.97M
Short % of Shares Out	12.48%
Short % of Float	24.59%
Short Ratio (days to cover)	1.32

Income Statement

In the last 12 months, SGMT had revenue of $2.00 million and -$29.25 million in losses. Loss per share was -$1.14.

Revenue	2.00M
Gross Profit	2.00M
Operating Income	-36.28M
Pretax Income	-27.92M
Net Income	-29.25M
EBITDA	n/a
EBIT	-36.28M
Loss Per Share	-$1.14

Full Income Statement

Balance Sheet

The company has $166.37 million in cash and $153,000 in debt, giving a net cash position of $188.34 million or $5.90 per share.

Cash & Cash Equivalents	166.37M
Total Debt	153,000
Net Cash	188.34M
Net Cash Per Share	$5.90
Equity (Book Value)	183.29M
Book Value Per Share	5.74
Working Capital	161.02M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.80M
Capital Expenditures	n/a
Free Cash Flow	-22.80M
FCF Per Share	-$0.71

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,813.75%
Pretax Margin	-1,462.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,144.50%

Dividends & Yields

SGMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13,667.47%
Shareholder Yield	-13,667.47%
Earnings Yield	-15.72%
FCF Yield	-12.26%

Analyst Forecast

The average price target for SGMT is $24.00, which is 311.66% higher than the current price. The consensus rating is "Buy".

Price Target	$24.00
Price Target Difference	311.66%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	116.53%
EPS Growth Forecast (5Y)	13.57%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGMT has an Altman Z-Score of 17.91 and a Piotroski F-Score of 2.

Altman Z-Score	17.91
Piotroski F-Score	2